|
2020
|
Invention
|
Compounds and matrices for use in bone growth and repair. Compositions of small molecules, matric... |
|
2017
|
Invention
|
Compounds as inhibitors of sodium channels. 8 are as described herein. |
|
|
Invention
|
Compounds as inhibitors of sodium channels. Methods and small molecule compounds for inhibition o... |
|
2016
|
Invention
|
Chemical and biochemical adducts as biomarkers for organophosphate exposure. Provided are methods... |
|
2013
|
Invention
|
Compounds for inhibition of cancer cell proliferation. 9 are as described herein. |
|
2012
|
Invention
|
Compounds for stem cell differentiation. Methods and small molecule compounds for stem cell diffe... |
|
|
Invention
|
Modulators of central nervous system neurotransmitters.
Disclosed are agents having pharmacologi... |
|
|
Invention
|
Compounds for stem cell differentiation. Small molecule compounds and methods for stem cell diffe... |
|
2011
|
Invention
|
Blood brain barrier-penetrating oximes for cholistenerases reactivation. The invention describes ... |
|
|
Invention
|
Synthetic compounds and methods to decrease nicotine self-administration. Methods and small molec... |
|
|
Invention
|
Compounds for stem cell differentiation.
Methods and small molecule compounds for stem cell diff... |
|
2010
|
Invention
|
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cance... |
|
2009
|
Invention
|
Small molecule immunomodulators for alzheimer's disease.
Disclosed are methods for identifying i... |
|
|
Invention
|
Small molecule immunomodulators for alzheimer's disease. Disclosed are methods for identifying in... |
|
|
Invention
|
Small molecule compounds for stem cell differentiation. Methods and small molecule compounds for ... |
|
|
Invention
|
Synthesis of metabolically stable agents for alcohol and drug abuse. The disclosed opioid-related... |
|
|
Invention
|
Synthesis of metabolically stable agents for alcohol and drug abuse. Disclosed herein are compoun... |
|
|
Invention
|
Chemical and biochemical adducts as biomarkers for organophosphate exposure.
OP-Peptide-Linker ... |
|
|
Invention
|
Chemical and biochemical adducts as biomarkers for organophosphate exposure. The invention provid... |
|
|
Invention
|
Chemical and biochemical adducts as biomarkers for organophosphate exposure. Provided is a method... |
|
|
Invention
|
Inhibitors of antigen receptor-induced nf-.kappa.b activation. A method to identify selective inh... |
|
|
Invention
|
Inhibitors of antigen receptor-induced nf-kappa b activation.
A method to identify selective inh... |
|
|
Invention
|
Inhibitors of antigen receptor-induced nf-кb activation. A method to identify selective inhibitor... |
|
|
Invention
|
Diagnostic methods and genetic markers for alzheimer disease.
Disclosed are methods for identify... |
|
2007
|
Invention
|
Curcumin analogs, diagnostic methods and genetic markers for diagnosing and treating alzheimer's ... |
|
|
Invention
|
Diagnostic methods and genetic markers for alzheimer disease. Disclosed are methods for identifyi... |
|
|
Invention
|
Novel methods for ester detoxication. This invention relates to a method for detoxication of inor... |
|
|
Invention
|
Methods for ester detoxication. This invention relates to a method for detoxication of inorganic ... |
|
|
Invention
|
Novel methods for ester detoxication.
This invention relates to a method for detoxication of ino... |
|
2005
|
Invention
|
Modulators of central nervous system neurotransmitters. Disclosed are agents having pharmacologic... |
|
|
Invention
|
Synthesis of metabolically stable analgesics, pain medications and other agents. Disclosed are an... |
